Patent · US Active

Film formulations containing dexmedetomidine and methods of producing them

US10792246B2 · kind B2 · utility

18Cited by
67References
26Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 26, 2019
Grant dateOct 6, 2020
Priority date
Expiry dateJun 26, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/22
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein is a self-supporting, dissolvable, film containing dexmedetomidine or a pharmaceutically acceptable salt thereof. The film is administered orally to treat various conditions, particularly agitation, by transmucosal delivery of the active agent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.